Consistent with the high prevalence of MSI and POLE subtype, BRAF/PIK3CA double mutant colorectal cancers in TCGA had a high Tumor Mutation Burden (TMB) above 200 in 86.4% of cases (Table 3). The gene discussed is BRAF; the disease is colorectal cancer.